Search hospitals
>
British Columbia
>
VANCOUVER
BCCA - Vancouver Cancer Centre
Claim this profile
VANCOUVER, British Columbia V5Z 4E6
Global Leader in Breast Cancer
Global Leader in Prostate Cancer
Conducts research for Cancer
Conducts research for Lung Cancer
Conducts research for Pancreatic Cancer
539 reported clinical trials
40 medical researchers
Summary
BCCA - Vancouver Cancer Centre is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Breast Cancer, Prostate Cancer, Cancer, Lung Cancer, Pancreatic Cancer and other specialties. BCCA - Vancouver Cancer Centre is involved with conducting 539 clinical trials across 383 conditions. There are 40 research doctors associated with this hospital, such as Zahi Mitri, Daniel J Renouf, MD, Anna Tinker, and Rebecca Harrison, MD.
Area of expertise
Breast Cancer
BCCA - Vancouver Cancer Centre has run 100 trials for Breast Cancer. Some of their research focus areas include:
Prostate Cancer
BCCA - Vancouver Cancer Centre has run 77 trials for Prostate Cancer. Some of their research focus areas include:
Top PIs
Zahi Mitri
OHSU Knight Cancer Institute
2 years of reported clinical research
Daniel J Renouf, MD
BC Cancer - Vancouver
1 year of reported clinical research
Anna Tinker
BC Cancer Vancouver
3 years of reported clinical research
Rebecca Harrison, MD
BC Cancer - The Vancouver Center
8 years of reported clinical research
Clinical Trials running at BCCA - Vancouver Cancer Centre
Bladder Cancer
Breast Cancer
Prostate Cancer
Lung Cancer
Cancer
Ovarian Cancer
Pancreatic Cancer
Melanoma
Solid Tumors
Multiple Myeloma
Disitamab Vedotin + Pembrolizumab vs Chemotherapy
for Bladder Cancer
This study will enroll participants with urothelial cancer (UC). UC can include cancer of the bladder, kidney, or the tubes that carry pee through the body (ureter, urethra). This study will try to find out if the drugs disitamab vedotin with pembrolizumab works better than platinum-containing chemotherapy to treat patients with UC. This study will also test what side effects happen when participants take these drugs together. A side effect is anything a drug does to the body besides treating the disease. Participants in this study will have cancer that has spread through the body (metastatic) or spread near where it started (locally advanced). In this study, there are 2 different groups. Participants will be assigned to a group randomly. Participants in the disitamab vedotin arm will get the study drug disitamab vedotin once every two weeks and pembrolizumab once every 6 weeks. Participants in the standard of care arm will get gemcitabine once a week for 2 weeks with either cisplatin or carboplatin once every 3 weeks.
Recruiting
2 awards
Phase 3
Blood Test and Immunotherapy
for Bladder Cancer
This phase II/III trial examines whether patients who have undergone surgical removal of bladder, kidney, ureter or urethra, but require an additional treatment called immunotherapy to help prevent their urinary tract (urothelial) cancer from coming back, can be identified by a blood test. Many types of tumors tend to lose cells or release different types of cellular products including their DNA which is referred to as circulating tumor DNA (ctDNA) into the bloodstream before changes can be seen on scans. Health care providers can measure the level of ctDNA in blood or other bodily fluids to determine which patients are at higher risk for disease progression or relapse. In this study, a blood test is used to measure ctDNA and see if there is still cancer somewhere in the body after surgery and if giving a treatment will help eliminate the cancer. Immunotherapy with monoclonal antibodies, such as nivolumab and relatlimab, can help the body's immune system to attack the cancer, and can interfere with the ability of tumor cells to grow and spread. This trial may help doctors determine if ctDNA measurement in blood can better identify patients that need additional treatment, if treatment with nivolumab prolongs patients' life and whether the additional immunotherapy treatment with relatlimab extends time without disease progression or prolongs life of urothelial cancer patients who have undergone surgical removal of their bladder, kidney, ureter or urethra.
Recruiting
1 award
Phase 2 & 3
10 criteria
Disitamab Vedotin + Pembrolizumab
for Bladder Cancer
This trial is testing a new drug called disitamab vedotin, alone or with pembrolizumab, for patients with advanced or metastatic HER2 expressing bladder cancer. Disitamab vedotin is designed to target HER2 and has been approved for other types of cancer. The study aims to see if these drugs can effectively treat the cancer and what side effects they might cause.
Recruiting
1 award
Phase 2
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at BCCA - Vancouver Cancer Centre?
BCCA - Vancouver Cancer Centre is a medical facility located in VANCOUVER, British Columbia. This center is recognized for care of Breast Cancer, Prostate Cancer, Cancer, Lung Cancer, Pancreatic Cancer and other specialties. BCCA - Vancouver Cancer Centre is involved with conducting 539 clinical trials across 383 conditions. There are 40 research doctors associated with this hospital, such as Zahi Mitri, Daniel J Renouf, MD, Anna Tinker, and Rebecca Harrison, MD.
Where is BCCA - Vancouver Cancer Centre located?
To reach the BC Cancer Agency in Vancouver by public transit, take the SkyTrain to Broadway-City Hall Station, then transfer to bus #99 B-Line towards UBC. Exit the bus at West 10th Avenue and Ash Street. For those driving, the address is 600 W 10th Ave, Vancouver, BC, with parking available via Ash Street at the corner of West 10th Avenue.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance queries related to cancer treatment in British Columbia, patients can contact the Canadian Cancer Society's Travel Treatment Fund at 1-888-939-3333 for financial grants and travel support. The BC Cancer Agency offers several financial support programs for cancer patients, such as the Financial Support Drug Program (FSDP), BC Palliative Care Benefits Program, and Additional Financial Resources for Patients. For more personalized assistance, the Patient and Family Counselling Department at the nearest Cancer Centre is available for contact.
What insurance does BCCA - Vancouver Cancer Centre accept?
**Insurance and Coverage at BCCA - Vancouver Cancer Centre:** - The BCCA - Vancouver Cancer Centre accepts a wide range of insurance plans, including commercial insurance, Medicare, Medicare Part C, some Medicaid, U.S. Department of Veterans Affairs, and TRICARE plans. - In British Columbia, the Medical Services Plan (MSP) covers necessary medical services, certain dental and oral surgeries, eye examinations, orthodontic services, diagnostic services, and supplementary benefits from other health care practitioners. - PharmaCare supports approved medications and medical supplies, while the Interim Federal Health Program offers limited coverage for protected persons without provincial or territorial health insurance.
What awards or recognition has BCCA - Vancouver Cancer Centre received?
The BC Cancer Research Institute, in partnership with the University of British Columbia, stands at the forefront of cancer research and care in British Columbia, Canada. Offering a comprehensive cancer control program alongside regional health authorities, the institute is dedicated to enhancing cancer care through a multifaceted research approach. This includes basic biomedical research, genomics, clinical trials, health services research, cancer surveillance, population health, and the creation of new technologies and interventions, supported by over sixty labs and numerous renowned scientists across the region.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.